The decision to pursue regenerative medicine is a significant one. Procedures are typically paid out of pocket, involve biological materials collected from your own body, and require a recovery period that affects daily life. Making this decision well requires evaluating not just whether the treatment might help your condition, but whether the specific clinic delivering it has the infrastructure, credentials, and clinical culture to do so responsibly.
This is complicated by the fact that the regenerative medicine field contains significant variation in practice quality. Some clinics operate with rigorous physician oversight, on-site laboratory capabilities, imaging-guided delivery, and honest patient communication. Others rely heavily on marketing language while delivering care that does not match the substance of the claims being made. Without a framework for evaluation, it is difficult for patients to tell the difference.
This article provides that framework, organized around the questions and observations that reveal the most about a clinic’s actual quality.
Why Clinic Quality Varies Significantly in This Field
Regulatory Context and What It Means for Patients
Understanding why variation exists requires understanding the regulatory landscape. Under FDA regulations, autologous cell procedures, those using cells taken from and returned to the same patient in a same-day, minimally manipulated procedure, occupy a specific regulatory space under Section 361 of the Public Health Service Act. This framework allows a range of autologous regenerative procedures without the full investigational approval process that would be required for cells that are more than minimally manipulated or used in non-homologous applications.
The existence of this regulatory space is not a problem in itself. Many legitimate, physician-led autologous procedures fall within it. However, the framework also creates variation, because the requirements within this space still depend heavily on physicians operating in compliance with applicable tissue practice regulations, state medical board standards, and professional ethics. The regulatory floor is not the same as the quality ceiling.
Patients sometimes encounter marketing language suggesting that a clinic’s procedures are “FDA approved.” Autologous same-day procedures under the 361 framework are not individually FDA-approved products in the way a pharmaceutical drug is approved; they operate under a framework that permits the practice. Knowing this distinction helps patients evaluate claims more accurately.
State medical boards provide oversight of physician conduct and can be searched for disciplinary records. This is publicly available information and a reasonable starting point for any physician you are considering as a provider for a significant procedure.
Why Marketing Claims Are Not a Reliable Signal
The regenerative medicine field has attracted significant marketing investment. Terms like “cutting-edge,” “revolutionary,” “proven,” and “breakthrough” appear routinely on clinic websites, in advertising, and in patient testimonials. These terms carry emotional weight, but they carry no clinical information.
Patient testimonials are not clinical evidence. A single patient who reports a positive outcome after a procedure tells you nothing about how the procedure performs across a diverse patient population, what percentage of patients achieve that result, or whether the outcome would have occurred without treatment. Before-and-after photos have no scientific controls. “Success stories” do not represent the full range of patient experiences at a clinic.
The substance of a clinic’s quality exists in things that do not make it into marketing materials. This includes the physician’s specific training and procedure volume, the laboratory infrastructure and quality documentation practices, the imaging equipment used for guided delivery, and how honestly the clinical team communicates about what is and is not known.
The Core Questions to Ask
Physician Credentials and Board Certification
The most important single question about a regenerative medicine clinic is who performs the procedures and what qualifications they hold. Physician-led care means that a licensed physician with appropriate training is conducting the clinical assessment, reviewing imaging, determining candidacy, and performing the procedure itself. Care in which a non-physician assesses candidacy and a physician appears only at the moment of injection does not meet the standard of physician-led care.
Relevant credentials include board certification in a specialty that encompasses the musculoskeletal system and injection-based procedures. Appropriate backgrounds include physical medicine and rehabilitation, orthopedic surgery, sports medicine, anesthesiology with pain management subspecialty training, and interventional pain management. The American Board of Regenerative Medicine (ABRM) offers a Diplomate certification specifically in regenerative medicine that requires documentation of clinical experience and successful examination.
Ask directly: which board certifications does the physician hold, what specialty is their training in, and who specifically performs your procedure. Also ask how many procedures they have performed for your specific condition. A physician who has performed hundreds of PRP injections for knee osteoarthritis has a meaningfully different experience base from one who performs regenerative procedures as a small fraction of their overall practice.
Lab Processing Model: In-House vs. External
As discussed in depth in a previous article in this series, the question of where your cells are processed reveals a great deal about a clinic’s infrastructure investment and commitment to quality control. Ask directly: are my cells processed in your facility or sent to an external laboratory? If external, ask where the lab is located, what their transport and cold chain protocol is, and whether you will receive documentation of the processed cell quality.
Clinics with in-house processing have made a capital investment in laboratory equipment, trained laboratory staff, and the workflow coordination required to run a same-day collection-and-injection protocol. This investment signals a commitment to quality control that is worth asking about and verifying.
If a clinic tells you their cells are processed externally, ask how they ensure quality. Ask whether they receive a cell count and viability report for each patient and whether that report is shared with the patient. A clinic that cannot or will not answer these questions directly is giving you information about their transparency standards.
Documentation Provided to Patients
Documentation is how a clinic demonstrates accountability. Ask what documentation you will receive from your procedure. A well-run clinic should be able to provide documentation that includes the cell count and viability of the material used, imaging guidance records confirming appropriate placement, a complete procedure note in your medical record, and a clear follow-up protocol with specific appointment milestones.
Ask whether your records will be releasable to other physicians involved in your care. If you see an orthopedic surgeon or your primary care physician after a regenerative procedure, they should be able to access documentation of what was done and how the cell product measured up to quality standards.
Imaging Guidance During Procedures
Precision in delivery is not optional for musculoskeletal regenerative procedures. Injections into joints, tendons, bursae, and other specific anatomical structures require confirmed accurate placement. The margins for error in some of these structures are measured in millimeters; injecting adjacent to rather than within the target structure reduces the biological effect and may mean the patient receives none of the intended benefit.
Ultrasound guidance provides real-time visualization of the needle relative to soft tissue structures, allowing the physician to confirm placement before injection. Fluoroscopy uses X-ray imaging to guide needle placement in spinal and deeper structures where ultrasound cannot provide adequate visualization. Clinics that do not use either of these guidance methods are performing what are called “landmark-guided” or “blind” injections, relying on anatomical landmarks to estimate placement rather than confirming it.
Ask directly: do you use ultrasound or fluoroscopy guidance for my specific procedure? Ask whether the equipment is on-site and whether the physician performing the procedure is trained in image-guided injection. The answer to this question is a meaningful quality differentiator.
What Transparency Looks Like in Practice
How Reputable Clinics Discuss Outcomes Honestly
Clinics that operate at a high standard of care communicate differently about outcomes than clinics focused primarily on attracting patients. Reputable clinics acknowledge the range of patient responses. They discuss what improvement looks like at realistic timepoints: four to eight weeks, three months, six months, one year. They acknowledge that not every patient achieves the same result and that clinical factors including the degree of existing damage, patient age, overall health, and adherence to post-procedure protocols all influence outcomes.
A hallmark of honest clinical communication is the willingness to tell patients when they are not good candidates. A physician who explains why your specific condition may not respond well to regenerative therapy, who recommends a different treatment or a referral for surgical evaluation when appropriate, and who discusses realistic expectations without overselling is demonstrating clinical integrity. This is significantly more reassuring than a physician who presents regenerative therapy as the right answer for every patient who walks through the door.
Ask the physician: what percentage of patients with my specific condition and degree of severity achieve meaningful improvement with this procedure? What does meaningful improvement mean in your clinical experience? What would make me a poor candidate? These questions put you in a position to hear honest answers rather than marketing language.
How Clinics Should Respond to Hard Questions
The quality of a clinic’s response to hard questions is itself diagnostic information. Ask the clinic to explain their laboratory process in specific terms. Ask what happens when a patient’s cell quality falls below acceptable levels on procedure day. Ask what their follow-up protocol looks like if a patient is not responding at three months. Ask whether they would refer you for surgery if that turns out to be the better option for your condition.
Reputable clinics answer these questions directly. They are not rattled by them. Physicians who have clinical confidence answer from experience, not from scripts. Clinics that deflect, become defensive, or pivot quickly back to marketing claims are telling you something important about how they handle patient concerns once you are actually in their care.
You should also feel comfortable asking about second opinions. Any physician who is uncomfortable with you seeking a second opinion from another qualified provider is not operating from a patient-first orientation.
Practical Steps Before You Commit
Consultation as an Evaluation Opportunity
The consultation is your primary evaluation tool. Use it fully. Come prepared with your imaging reports, prior treatment records, and a list of specific questions. Observe how the physician communicates: do they speak in clinical terms that are explained clearly, or do they rely on vague language that sounds impressive but contains little specific information? Do they ask about your goals and priorities, or do they move quickly toward presenting a treatment plan?
Notice whether the physician discusses your condition honestly, including what is unlikely to improve with regenerative therapy as well as what might. Notice whether staff communicate respectfully and whether your questions are treated as reasonable rather than inconvenient.
A consultation that feels like a sales process, where you are moved quickly toward a financial commitment without sufficient time for your questions, is a red flag regardless of how impressive the clinic’s marketing appears.
How to Compare Two or More Clinics
If you are considering more than one clinic, bring the same set of core questions to each consultation and compare the answers. Ask each clinic: who performs the procedure, in-house or external processing, what imaging guidance is used, what documentation will I receive, and what is your experience with my specific condition?
Significant differences in the answers to these questions reveal meaningful differences in how each clinic operates. A clinic that processes in-house, provides cell quality documentation, uses ultrasound guidance, and communicates honestly about outcomes is operating at a different standard than one that sends cells to an external lab, cannot describe its documentation practices, and makes broad outcome promises.
In the specific case of regenerative medicine, infrastructure and clinical rigor are not peripheral details. They directly affect what happens to your cells and, by extension, the biological activity of the treatment you receive.
Sources
- FDA Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers (FDA Guidance Document)
- Ethical and Regulatory Considerations Related to Regenerative Medicine (PMC)
- The Evolving Regulatory Landscape in Regenerative Medicine (PMC)
- FDA’s Framework for Regulating Regenerative Medicine Will Improve Oversight (Pew Charitable Trusts)
- Verify Physician Board Certification (American Board of Medical Specialties)
- On Patient Safety: Regenerative Medicine — The Hype Amplifies Safety Concerns (PMC)
Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. This content is not a substitute for consultation with a qualified, licensed healthcare provider. Regenerative medicine procedures vary in outcomes based on individual health status, condition severity, and other clinical factors. No specific results are guaranteed. Consult a board-certified physician to determine whether any treatment discussed here is appropriate for your situation.